TY  - BOOK
AU  - Di Giovanni,Giuseppe
AU  - Di Matteo,Vincenzo
AU  - Esposito,Ennio
TI  - Serotonin-Dopamine Interaction: Experimental Evidence and Therapeutic Relevance 
T2  - Progress in brain research,
SN  - 9780080932682
AV  - QP376 .P7 v.172eb
U1  - 612.8042 22
PY  - 2008///
CY  - Amsterdam, New York
PB  - Elsevier
KW  - Serotonin
KW  - Physiological effect
KW  - Research
KW  - Therapeutic use
KW  - Antagonists
KW  - Dopamine
KW  - Agonists
KW  - Neurotransmitters
KW  - Neurochemistry
KW  - Drug interactions
KW  - Pharmacology
KW  - physiology
KW  - Neurotransmitter Agents
KW  - Dopamine Agonists
KW  - Drug Interactions
KW  - Serotonin Receptor Agonists
KW  - Neurochimie
KW  - Neurotransmetteurs
KW  - Sérotonine
KW  - Effets physiologiques
KW  - Recherche
KW  - Emploi en thérapeutique
KW  - Antisérotonines
KW  - Agonistes
KW  - Interactions médicamenteuses
KW  - Pharmacologie
KW  - pharmacology
KW  - aat
KW  - MEDICAL
KW  - Neuroscience
KW  - bisacsh
KW  - PSYCHOLOGY
KW  - Neuropsychology
KW  - fast
KW  - Festschriften
KW  - lcgft
N1  - Includes bibliographical references and index; 1. SEROTONIN-DOPAMINE INTERACTIONS IN THE CENTRAL NERVOUS SYSTEM; 1. Serotonin-Dopamine Interaction: an overview; 2. Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies; 3. Serotonin-Dopamine Interaction: electrophysiological evidence; 4. Functional genetic polymorphisms in serotonin and dopamine gene systems and their significance in behavioural disorders; ; 2. SEROTONIN-DOPAMINE INTERACTIONS IN SCHIZOPHRENIA; 5. Distribution of 5-HT and DA receptors in primate prefrontal cortex: implications for pathophysiology and treatment; 6. Alterations of dopamine and serotonin transmission in schizophrenia; 7. Serotonin and dopamine interactions in psychosis prevention; 8. Role of serotonin and dopamine receptor binding in antipsychotic efficacy; 9. In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems; 10; Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis; 11. Serotonin-dopamine interactions: implications for the design of novel therapeutic agents for psychiatric disorders; ; 3. SEROTONIN-DOPAMINE INTERACTIONS IN DEPRESSION; 12. The dorsal raphe nucleus and serotonin -implications for neuroplasticity linked to major depression and Alzheimer's disease; 13. Dynamics of the dopaminergic system as a key component to the understanding of depression; 14. Physiological and therapeutic relevance of constitutive activity of 5-HT2A and 5-HT2C receptors for the treatment of depression; 15. The role of dopamine and serotonin in suicidal behaviour and aggression; ; 4. SEROTONIN-DOPAMINE INTERACTIONS IN DRUG ADDICTION; 16. Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse; 17; Pharmacological inhibition of dopamine- and serotonin activity blocks spontaneous and cocaine-activated behaviour; 18. Serotonin receptors as potential targets for modulation of nicotine use and dependence; 19. Dopamine/Serotonin releasers as medications for stimulant addictions; 20. PTEN-5-HT2C coupling: A new target for treating drug addiction; ; 5. SEROTONIN-DOPAMINE INTERACTIONS IN MOTOR DISORDERS; 21. Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders; 22. Serotonin-Dopamine interaction in the induction and maintenance of LDOPA-induced dyskinesias; 23. Parkinson's disease -- opportunities for novel therapeutics to reduce the problems of levodopa therapy; 24. Neurobiological basis of serotonin-dopamine antagonists in the treatment of Gilles de la Tourette syndrome; ; 6. SEROTONIN-DOPAMINE INTERACTIONS IN ATTENTIONAL PROCESSES, LEARNING AND MEMORY; 25; Serotonergic and dopaminergic modulation of attentional processes; 26. Dopamine-serotonin interactions in attention-deficit/hyperactivity disorder (ADHD); 27. Serotonin/dopamine interaction in learning; 28. Serotonin-dopamine interaction in memory formation; 29. The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking
N2  - This book provides a unique and timely multidisciplinary synthesis of our current knowledge of the anatomy, pharmacology, physiology and behavioral data of the serotonin (5-HT)-dopamine (DA) interactions. Central serotonergic and dopaminergic systems play a critical role in the regulation of normal and abnormal behaviors. Moreover, recent evidence suggests that the dysfunction of the DA and 5-HT neurotransmitter systems contribute to various mental disorders including depression, schizophrenia, drug addiction and Parkinson?s disease. This extremely important topic is of wide interest within th
UR  - https://www-sciencedirect-com.libraryproxy.ist.ac.at/science/bookseries/00796123/172
ER  -